Tumour growth rate (TGR) to monitor growth/predict response to lanreotide autogel (LAN) use before, during and after peptide receptor radionuclide therapy (PRRT)) in advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs): data from PRELUDE
Prasad, V Srirajaskanthan, R Grana, C Baldari, S Shah, T Lamarca, Angela Courbon, F Scheidhauer, K Baudin, E Thanh, X
Prasad, V
Srirajaskanthan, R
Grana, C
Baldari, S
Shah, T
Lamarca, Angela
Courbon, F
Scheidhauer, K
Baudin, E
Thanh, X
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2019
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Prasad V, Srirajaskanthan R, Grana C, Baldari S, Shah T, Lamarca A, et al. Tumour growth rate (TGR) to monitor growth/predict response to lanreotide autogel (LAN) use before, during and after peptide receptor radionuclide therapy (PRRT)) in advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs): data from PRELUDE. Neuroendocrinology. 2019;108:158.